STOCK TITAN

OrthoPediatrics Corp. - KIDS STOCK NEWS

Welcome to our dedicated page for OrthoPediatrics news (Ticker: KIDS), a resource for investors and traders seeking the latest updates and insights on OrthoPediatrics stock.

OrthoPediatrics Corp. (symbol: KIDS) is a global leader in pediatric orthopedics, exclusively focusing on providing innovative solutions for children with orthopedic conditions and injuries. The company is dedicated to advancing pediatric orthopedics by developing state-of-the-art technologies, ensuring high-quality products, and offering unparalleled support and clinical education through its team of experts.

OrthoPediatrics offers a wide range of anatomically appropriate implants and instruments designed to meet the unique needs of pediatric orthopedic surgeons. Their product portfolio includes solutions for long bone deformity correction and trauma, spine, and sports medicine. Among their flagship products are PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and the ACL Reconstruction System.

Recent achievements of OrthoPediatrics include issuing the 2024 financial guidance and recording a full-year revenue of $148.7 million in 2023, marking a 22% increase compared to the previous year. As of December 31, 2023, the company had cash and cash equivalents, short-term investments, and restricted cash totaling $82.3 million. The recent acquisition of Boston Orthotics & Prosthetics was a significant milestone, further reinforcing their market position.

In the first quarter of 2024, OrthoPediatrics reported a 41% increase in revenue year-over-year. The company's total other expense was $0.6 million for the quarter, primarily due to a favorable fair value adjustment in the previous year that did not recur in 2024, as well as additional interest expenses related to a new term loan with MidCap. As of March 31, 2024, the company's cash, cash equivalents, short-term investments, and restricted cash were $49.7 million.

OrthoPediatrics continues to seek talented professionals to join their mission. Interested candidates can visit their website to learn about current openings or submit their resumes to careers@orthopediatrics.com. For the latest updates, news, and developments, shareholders and potential investors can find the most recent information on OrthoPediatrics Corp. through this page.

Rhea-AI Summary

OrthoPediatrics Corp. (Nasdaq: KIDS), a company dedicated to pediatric orthopedics, announced participation in the Truist Securities MedTech Conference. President & CEO Dave Bailey will join a fireside chat on June 18, 2024, at 4:45 pm ET in Boston, MA. An audio webcast of the discussion will be accessible on OrthoPediatrics' investor relations website, with a replay available post-event.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.67%
Tags
conferences
-
Rhea-AI Summary

OrthoPediatrics Corp. (NASDAQ: KIDS) announced its continued sponsorship at the 2024 Pediatric Orthopaedic Society of North America (POSNA) and European Paediatric Orthopaedic Society (EPOS) annual meeting.

The company featured its expanding range of pediatric-specific orthopedic solutions at its exhibit booth. It sponsored a session on decision-making in the orthopedic management of neuromuscular patients, led by physicians from top children's hospitals.

OrthoPediatrics is deeply committed to supporting POSNA and EPOS, offering educational grants and scholarships. It remains the only Emerald Sponsor of the meeting. President & CEO David Bailey emphasized the importance of collaboration with these organizations to advance pediatric orthopedics and praised the productive engagement with thought leaders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.34%
Tags
none
-
Rhea-AI Summary

OrthoPediatrics Corp. reported a 41% increase in revenue for the first quarter of 2024 compared to the same period last year, reaching $44.7 million. The Company helped nearly 28,000 children, with domestic revenue up by 44% and international revenue up by 33%. OrthoPediatrics experienced growth in Trauma & Deformity, Scoliosis, and Sports Medicine/Other revenue streams. The acquisition of Boston Orthotics & Prosthetics enhanced the Specialty Bracing Division. The full year 2024 revenue guidance was increased to $200.0-$203.0 million from $197.0-$200.0 million, showcasing a growth of 34%-36% over the previous year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.27%
Tags
Rhea-AI Summary

OrthoPediatrics Corp. has received the 'Breakthrough Device' Designation from the FDA for its new eLLi Growing Rod System, designed to treat pediatric patients with scoliosis. The device aims to address severe pathology associated with Early Onset Scoliosis, providing increased force, enhanced reliability, and precision, while improving safety. The Breakthrough Program expedites the development and review of medical devices for life-threatening conditions, allowing for timely access to innovative technologies. OrthoPediatrics' CEO, David Bailey, expressed pride in the team's achievement and commitment to advancing pediatric healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.21%
Tags
-
Rhea-AI Summary
OrthoPediatrics Corp. is set to disclose its first quarter 2024 financial results on May 6, 2024, followed by a conference call on May 7, 2024. Investors can access the event through a live webcast on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.42%
Tags
conferences earnings
-
Rhea-AI Summary
OrthoPediatrics Corp. (NASDAQ: KIDS) announces its participation in the 8th Annual International Children’s Spine Symposium to showcase its RESPONSE™ portfolio for Scoliosis surgery and new Rib and Pelvic Fixation system. The company aims to enhance patient outcomes and provide educational grants for medical professionals.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.83%
Tags
none
Rhea-AI Summary
OrthoPediatrics Corp. to participate in fireside chat at the 23rd Annual Needham Virtual Healthcare Conference. Dave Bailey and Fred Hite to discuss advancements in pediatric orthopedics on April 9, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.15%
Tags
conferences
-
Rhea-AI Summary
OrthoPediatrics Corp. reports a record full-year 2023 revenue of $148.7 million, up 22% from the prior year. The company helped nearly 20,000 children in Q4 2023 and 82,000 in full-year 2023, with total assistance to over 710,000 kids. They generated $37.6 million in revenue in Q4 2023, a 21% increase from Q4 2022. OrthoPediatrics achieved record full-year adjusted EBITDA of $5.0 million in 2023 and launched 8 new products. The acquisition of Boston Orthotics & Prosthetics expanded their offerings. The company strengthened its balance sheet with an $80 million debt financing. They reiterated full-year 2024 revenue guidance of $197.0 million to $200.0 million, anticipating 32% to 34% growth compared to 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.64%
Tags
-
Rhea-AI Summary
OrthoPediatrics Corp. announced the launch of the RESPONSE™ Rib and Pelvic Fixation system to treat children with Early Onset Scoliosis. This marks the company's 71st system for pediatric orthopedic conditions, providing implants and instruments for rib and pelvic fixation. The system offers a variety of implant options, low profile implants, rib hooks, and locking options. It is compatible with existing RESPONSE™ Systems, allowing comprehensive treatment for scoliosis patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.55%
Tags
none
Rhea-AI Summary
OrthoPediatrics Corp. (KIDS) has been named one of the 2024 Best Places to Work in Indiana for the 8th time. The company focuses on pediatric orthopedics and is committed to fostering a positive culture. OrthoPediatrics President & CEO looks forward to receiving detailed feedback to enhance the organization further.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.24%
Tags
none

FAQ

What is the current stock price of OrthoPediatrics (KIDS)?

The current stock price of OrthoPediatrics (KIDS) is $22.87 as of January 2, 2025.

What is the market cap of OrthoPediatrics (KIDS)?

The market cap of OrthoPediatrics (KIDS) is approximately 546.1M.

What does OrthoPediatrics Corp. do?

OrthoPediatrics Corp. designs, develops, and commercializes implants and instruments specifically for pediatric orthopedic surgeons to treat children with orthopedic conditions and injuries.

What are some of OrthoPediatrics' key products?

Key products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and the ACL Reconstruction System.

What were OrthoPediatrics' financial highlights for 2023?

OrthoPediatrics recorded a full-year revenue of $148.7 million in 2023, a 22% increase compared to the prior year.

How did OrthoPediatrics perform in the first quarter of 2024?

In the first quarter of 2024, OrthoPediatrics reported a 41% increase in revenue year-over-year, with total other expense at $0.6 million.

What recent acquisition did OrthoPediatrics make?

OrthoPediatrics recently acquired Boston Orthotics & Prosthetics, further reinforcing their market position.

How much cash and equivalents did OrthoPediatrics have as of March 31, 2024?

As of March 31, 2024, OrthoPediatrics had $49.7 million in cash, cash equivalents, short-term investments, and restricted cash.

What is OrthoPediatrics' focus in pediatric orthopedics?

OrthoPediatrics focuses on advancing pediatric orthopedics by developing state-of-the-art technologies, high-quality products, and offering industry-leading support and clinical education.

Where can I learn about career opportunities at OrthoPediatrics?

You can learn about current openings and career opportunities at OrthoPediatrics by visiting their website or submitting a resume to careers@orthopediatrics.com.

Who can I contact for investor relations at OrthoPediatrics?

For investor relations, you can contact Philip Taylor at Gilmartin Group via email at philip@gilmartinir.com or phone at 415-937-5406.

What recent financial guidance did OrthoPediatrics issue?

OrthoPediatrics recently issued their 2024 financial guidance, which includes detailed projections and expectations for the year.
OrthoPediatrics Corp.

Nasdaq:KIDS

KIDS Rankings

KIDS Stock Data

546.07M
16.34M
32.52%
71.05%
3.63%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
WARSAW